
Tooth extraction in patients on chronic anticoagulant treatment – preliminary results of a clinical prospective study
Author(s) -
Rareș Călin Roman,
Andreea Miron,
Horațiu Rotaru,
Mădălina-Ana Văleanu,
Cristian-Niky Cumpătă,
Dragoş Ţermure,
Spitalul Clinic Judeţean de Urgenţă Cluj-Napoca,
Universitatea „Titu Maiorescu“ Bucureşti Facultatea de Medicină Dentară
Publication year - 2015
Publication title -
romanian journal of stomatology
Language(s) - English
Resource type - Journals
eISSN - 2069-6078
pISSN - 1843-0805
DOI - 10.37897/rjs.2015.4.5
Subject(s) - medicine , hemostat , anticoagulant , warfarin , dental extraction , anticoagulant drug , oral anticoagulant , heparin , prospective cohort study , ambulatory , surgery , anesthesia , dentistry , atrial fibrillation
Patients under anticoagulant treatment which needs dental extractions have a significant high risk of postoperative bleeding, in consequence they need either hospitalization or ambulatory postextractional monitoring. The objective of this study was while using Surgicel® as a socket local hemostat for extractions at patients under anticoagulants to prove his efficacy during a clinical prospective experimental study. We followed three groups of patients under anticoagulant treatment with single or multiple dental extractions: one group under oral anticoagulants (warfarin) and socket meshing with Surgicel®, one group under i.v. anticoagulants (heparin) and one control group under antithrombotics. Many parameters were observed and studied with special focus on postextractional hemorrhage. Results were statistically analyzed and they were compared with the latest findings on international literature. The study conclusions suggest using Surgicel® as viable intraalveolar hemostat which can reduce many postoperative bleeding accidents and avoid thrombotic risks associated with suppression of oral anticoagulant or heparin treatment.